HMSTR / USDT

HMSTR / TRY

HMSTR / USDC

HMSTR / FDUSD

BARD / BNB

BARD / USDT

BARD / TRY

BARD / USDC

BARD / FDUSD

ACT / TRY

SCR / IDR

GHST / USDT

PROM / USDT

ALT / BTC

RLC / ETH

CTK / BTC

OG / BTC

SXP / BTC

GUN / BNB

ZKC / FDUSD

VIVIMED LABS LIMITED

KATARIA INDUSTRIES LTD

ANTONY WASTE HDG CELL LTD

TCIFINANCELTD-ROLL SETT

ARVEE LABORATORIES I LTD

AMIABLE LOGISTICS (I) LTD

DSJ KEEP LEARNING LTD

WALCHANDNAGAR INDUSTRIES

GVP INFOTECH LIMITED

GABRIEL INDIA LTD

WONDER ELECTRICALS LTD

MANGLAM INFRA & ENG LTD

S A TECH SOFTWARE INDIA L

CEDAAR TEXTILE LIMITED

TRANSWARRANTY FIN. LTD.

TUNWAL E-MOTORS LIMITED

JHS SVENDGAARD RETAIL V L

TIJARIA POLYPIPES LTD

VAIDYA SANE AYUR LAB LTD

ESSEN SPECIALITY FILMS L

Click here to get full coverage on Glenmark bags multi-regional rights to Hansoh Pharma’s oncology drug for $1 B - BioSpectrum Asia

Glenmark bags multi-regional rights to Hansoh Pharma’s oncology drug for $1 B  BioSpectrum Asia

Glenmark bags multi-regional rights to Hansoh Pharma’s oncology drug for $1 B - BioSpectrum Asia

Click here to get full coverage on NJ-based Glenmark Pharmaceuticals recalls blood pressure medication - Bergen Record

NJ-based Glenmark Pharmaceuticals recalls blood pressure medication  Bergen Record

NJ-based Glenmark Pharmaceuticals recalls blood pressure medication - Bergen Record

Click here to get full coverage on Popular blood pressure medication recalled: Complete list of products - AL.com

Popular blood pressure medication recalled: Complete list of products  AL.com

Popular blood pressure medication recalled: Complete list of products - AL.com

Click here to get full coverage on FDA Announces Nationwide Recall of Common Blood Pressure Medication—More Than 11,000 Bottles Affected - Health: Trusted and Empathetic Health and Wellness Information

FDA Announces Nationwide Recall of Common Blood Pressure Medication—More Than 11,000 Bottles Affected  Health: Trusted and Empathetic Health and Wellness Information

FDA Announces Nationwide Recall of Common Blood Pressure Medication—More Than 11,000 Bottles Affected - Health: Trusted and Empathetic Health and Wellness Information

Click here to get full coverage on The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year - ProPublica

The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year  ProPublica

The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year - ProPublica

Click here to get full coverage on Hansoh Pharmaceutical says unit enters license agreement with Glenmark for aumolertinib - marketscreener.com

Hansoh Pharmaceutical says unit enters license agreement with Glenmark for aumolertinib  marketscreener.com

Hansoh Pharmaceutical says unit enters license agreement with Glenmark for aumolertinib - marketscreener.com

Click here to get full coverage on FDA recalling blood pressure medication used by thousands: Is your medicine affected? - NJ.com

FDA recalling blood pressure medication used by thousands: Is your medicine affected?  NJ.com

FDA recalling blood pressure medication used by thousands: Is your medicine affected? - NJ.com

Click here to get full coverage on Hansoh Pharma Enters Global Licensing Agreement with Glenmark for Aumolertinib - TipRanks

Hansoh Pharma Enters Global Licensing Agreement with Glenmark for Aumolertinib  TipRanks

Hansoh Pharma Enters Global Licensing Agreement with Glenmark for Aumolertinib - TipRanks

Click here to get full coverage on Glenmark secures multi-regional rights for Hansoh’s lung cancer drug Aumolertinib - ETPharma.com

Glenmark secures multi-regional rights for Hansoh’s lung cancer drug Aumolertinib  ETPharma.com

Glenmark secures multi-regional rights for Hansoh’s lung cancer drug Aumolertinib - ETPharma.com

Click here to get full coverage on it looks for Glenmark more upside left before any major correction.Chart is from covid low .there are - Market Sentiment Report & Watch and Learn From Live Trades - Bollywood Helpline

it looks for Glenmark more upside left before any major correction.Chart is from covid low .there are - Market Sentiment Report & Watch and Learn From Live Trades  Bollywood Helpline

it looks for Glenmark more upside left before any major correction.Chart is from covid low .there are - Market Sentiment Report & Watch and Learn From Live Trades - Bollywood Helpline

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial - PR Newswire

Click here to get full coverage on FDA recalls blood pressure medication over cholesterol drug contamination - Fox Business

FDA recalls blood pressure medication over cholesterol drug contamination  Fox Business

FDA recalls blood pressure medication over cholesterol drug contamination - Fox Business

Click here to get full coverage on India's Glenmark posts higher quarterly profit on strong demand in N.America, Europe - Reuters

India's Glenmark posts higher quarterly profit on strong demand in N.America, Europe  Reuters

India's Glenmark posts higher quarterly profit on strong demand in N.America, Europe - Reuters

Click here to get full coverage on In potential $1.1B deal, Glenmark grabs certain rights to Hengrui's ADC rival to Enhertu - Fierce Pharma

In potential $1.1B deal, Glenmark grabs certain rights to Hengrui's ADC rival to Enhertu  Fierce Pharma

In potential $1.1B deal, Glenmark grabs certain rights to Hengrui's ADC rival to Enhertu - Fierce Pharma

Click here to get full coverage on What Technical Tools Say About Glenmark Pharmaceuticals Limited Recovery - High Dividend Yield Stocks & Exceptional Return Capital - Bollywood Helpline

What Technical Tools Say About Glenmark Pharmaceuticals Limited Recovery - High Dividend Yield Stocks & Exceptional Return Capital  Bollywood Helpline

What Technical Tools Say About Glenmark Pharmaceuticals Limited Recovery - High Dividend Yield Stocks & Exceptional Return Capital - Bollywood Helpline

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials - PR Newswire

Click here to get full coverage on Glenmark Pharmaceuticals : Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma - marketscreener.com

Glenmark Pharmaceuticals : Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma  marketscreener.com

Glenmark Pharmaceuticals : Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma - marketscreener.com

Click here to get full coverage on Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe - PR Newswire

Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe  PR Newswire

Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe - PR Newswire

Click here to get full coverage on Glenmark Pharmaceuticals Limited Breakout Confirmed by Volume Metrics - High Beta Stocks & Minimal Capital Appreciation - earlytimes.in

Glenmark Pharmaceuticals Limited Breakout Confirmed by Volume Metrics - High Beta Stocks & Minimal Capital Appreciation  earlytimes.in

Glenmark Pharmaceuticals Limited Breakout Confirmed by Volume Metrics - High Beta Stocks & Minimal Capital Appreciation - earlytimes.in

Click here to get full coverage on Glenmark in $1B deal for Hengrui's HER2-targeted antibody-drug conjugate - firstwordpharma.com

Glenmark in $1B deal for Hengrui's HER2-targeted antibody-drug conjugate  firstwordpharma.com

Glenmark in $1B deal for Hengrui's HER2-targeted antibody-drug conjugate - firstwordpharma.com

Click here to get full coverage on Glenmark Inks Licensing Pact With Chinas Hansoh Pharma For Cancer Drug - NDTV Profit

Glenmark Inks Licensing Pact With Chinas Hansoh Pharma For Cancer Drug  NDTV Profit

Glenmark Inks Licensing Pact With Chinas Hansoh Pharma For Cancer Drug - NDTV Profit

Click here to get full coverage on Recall alert: Blood pressure medication recalled; may be contaminated with wrong drug - Boston 25 News

Recall alert: Blood pressure medication recalled; may be contaminated with wrong drug  Boston 25 News

Recall alert: Blood pressure medication recalled; may be contaminated with wrong drug - Boston 25 News

Click here to get full coverage on Can Glenmark Pharmaceuticals Limited Bounce Back From Weekly Low - Insider Trading Compliance & Smarter Trades Backed by Machine Learning - Bollywood Helpline

Can Glenmark Pharmaceuticals Limited Bounce Back From Weekly Low - Insider Trading Compliance & Smarter Trades Backed by Machine Learning  Bollywood Helpline

Can Glenmark Pharmaceuticals Limited Bounce Back From Weekly Low - Insider Trading Compliance & Smarter Trades Backed by Machine Learning - Bollywood Helpline

Click here to get full coverage on Glenmark unit signs exclusive licensing pact with Hansoh Pharma for NSCLC drug Aumolertinib - CNBC TV18

Glenmark unit signs exclusive licensing pact with Hansoh Pharma for NSCLC drug Aumolertinib  CNBC TV18

Glenmark unit signs exclusive licensing pact with Hansoh Pharma for NSCLC drug Aumolertinib - CNBC TV18

Click here to get full coverage on Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter - Fierce Pharma

Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter  Fierce Pharma

Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter - Fierce Pharma

Click here to get full coverage on Data, Differentiation, and the Future of Healthcare in Mexico - Mexico Business News

Data, Differentiation, and the Future of Healthcare in Mexico  Mexico Business News

Data, Differentiation, and the Future of Healthcare in Mexico - Mexico Business News

Click here to get full coverage on FDA warns Glenmark for failure to investigate dissolution failures - Regulatory Affairs Professionals Society | RAPS

FDA warns Glenmark for failure to investigate dissolution failures  Regulatory Affairs Professionals Society | RAPS

FDA warns Glenmark for failure to investigate dissolution failures - Regulatory Affairs Professionals Society | RAPS

Click here to get full coverage on AbbVie to pay $700M for trispecific drug from Ichnos Glenmark - BioPharma Dive

AbbVie to pay $700M for trispecific drug from Ichnos Glenmark  BioPharma Dive

AbbVie to pay $700M for trispecific drug from Ichnos Glenmark - BioPharma Dive

Click here to get full coverage on Glenmark Pharmaceuticals Limited Nearing Breakout Level After Bounce - AI-Driven Market Analysis & Explosive Growth Opportunities - Bollywood Helpline

Glenmark Pharmaceuticals Limited Nearing Breakout Level After Bounce - AI-Driven Market Analysis & Explosive Growth Opportunities  Bollywood Helpline

Glenmark Pharmaceuticals Limited Nearing Breakout Level After Bounce - AI-Driven Market Analysis & Explosive Growth Opportunities - Bollywood Helpline

Click here to get full coverage on Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811) - Yahoo Finance

Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)  Yahoo Finance

Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811) - Yahoo Finance

Click here to get full coverage on India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal - Reuters

India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal  Reuters

India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal - Reuters

Click here to get full coverage on Glenmark 3.0 In The Making, Invigorated By IGI-AbbVie Deal - Citeline News & Insights

Glenmark 3.0 In The Making, Invigorated By IGI-AbbVie Deal  Citeline News & Insights

Glenmark 3.0 In The Making, Invigorated By IGI-AbbVie Deal - Citeline News & Insights

Click here to get full coverage on Glenmark Specialty Enters $1 Billion Exclusive License Agreement with Hengrui for Trastuzumab Rezetecan - PharmExec.com

Glenmark Specialty Enters $1 Billion Exclusive License Agreement with Hengrui for Trastuzumab Rezetecan  PharmExec.com

Glenmark Specialty Enters $1 Billion Exclusive License Agreement with Hengrui for Trastuzumab Rezetecan - PharmExec.com

Click here to get full coverage on Latham & Watkins Advises AbbVie on US$1.925 Billion Licensing Agreement With Ichnos Glenmark Innovation - Latham & Watkins LLP

Latham & Watkins Advises AbbVie on US$1.925 Billion Licensing Agreement With Ichnos Glenmark Innovation  Latham & Watkins LLP

Latham & Watkins Advises AbbVie on US$1.925 Billion Licensing Agreement With Ichnos Glenmark Innovation - Latham & Watkins LLP

Click here to get full coverage on Stocks to watch: Reliance, Ola Electric, IOB, Akzo Nobel, Glenmark among shares in focus - BusinessLine

Stocks to watch: Reliance, Ola Electric, IOB, Akzo Nobel, Glenmark among shares in focus  BusinessLine

Stocks to watch: Reliance, Ola Electric, IOB, Akzo Nobel, Glenmark among shares in focus - BusinessLine

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial) - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial) - PR Newswire

Click here to get full coverage on Fierce Pharma Asia—Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal - Fierce Pharma

Fierce Pharma Asia—Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal  Fierce Pharma

Fierce Pharma Asia—Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal - Fierce Pharma

Click here to get full coverage on Glenmark Unit Signs Exclusive NSCLC Drug Pact with Hansoh Pharma; Shares Drop 1% - Equitypandit

Glenmark Unit Signs Exclusive NSCLC Drug Pact with Hansoh Pharma; Shares Drop 1%  Equitypandit

Glenmark Unit Signs Exclusive NSCLC Drug Pact with Hansoh Pharma; Shares Drop 1% - Equitypandit

Click here to get full coverage on China’s Hengrui Rises After Licensing Cancer Drug to India's Glenmark in Up to USD1.1 Billion Deal - Yicai Global

China’s Hengrui Rises After Licensing Cancer Drug to India's Glenmark in Up to USD1.1 Billion Deal  Yicai Global

China’s Hengrui Rises After Licensing Cancer Drug to India's Glenmark in Up to USD1.1 Billion Deal - Yicai Global

Click here to get full coverage on An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients - ProPublica

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients  ProPublica

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients - ProPublica

Click here to get full coverage on Glenmark Pharma stock gains 3% on launch novel COPD treatment; details here - Business Standard

Glenmark Pharma stock gains 3% on launch novel COPD treatment; details here  Business Standard

Glenmark Pharma stock gains 3% on launch novel COPD treatment; details here - Business Standard

Click here to get full coverage on Glenmark Pharma Secures Exclusive Aumolertinib Rights Across Multiple Regions - scanx.trade

Glenmark Pharma Secures Exclusive Aumolertinib Rights Across Multiple Regions  scanx.trade

Glenmark Pharma Secures Exclusive Aumolertinib Rights Across Multiple Regions - scanx.trade

Click here to get full coverage on AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B - BioSpace

AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B  BioSpace

AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B - BioSpace

Click here to get full coverage on AbbVie steps up for Glenmark's multispecific | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

AbbVie steps up for Glenmark's multispecific | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

AbbVie steps up for Glenmark's multispecific | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Click here to get full coverage on Specialty entry a positive for Glenmark; cautious on Ola, DMart amid rising competition: Amnish Aggarwal - The Economic Times

Specialty entry a positive for Glenmark; cautious on Ola, DMart amid rising competition: Amnish Aggarwal  The Economic Times

Specialty entry a positive for Glenmark; cautious on Ola, DMart amid rising competition: Amnish Aggarwal - The Economic Times

Click here to get full coverage on Glenmark to launch Leucovorin generic in US - ETPharma.com

Glenmark to launch Leucovorin generic in US  ETPharma.com

Glenmark to launch Leucovorin generic in US - ETPharma.com

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials - PR Newswire

Click here to get full coverage on Hengrui and Glenmark agree $1.1 billion trastuzumab rezetecan rights deal - The Pharma Letter

Hengrui and Glenmark agree $1.1 billion trastuzumab rezetecan rights deal  The Pharma Letter

Hengrui and Glenmark agree $1.1 billion trastuzumab rezetecan rights deal - The Pharma Letter

Click here to get full coverage on India's Glenmark Pharma unit, AbbVie sign exclusive licensing pact - Reuters

India's Glenmark Pharma unit, AbbVie sign exclusive licensing pact  Reuters

India's Glenmark Pharma unit, AbbVie sign exclusive licensing pact - Reuters

Click here to get full coverage on Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)  PR Newswire

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Click here to get full coverage on Glenmark launches fixed-dose triple therapy for COPD - The Economic Times

Glenmark launches fixed-dose triple therapy for COPD  The Economic Times

Glenmark launches fixed-dose triple therapy for COPD - The Economic Times

Click here to get full coverage on AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer - Fierce Biotech

AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer  Fierce Biotech

AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer - Fierce Biotech

Click here to get full coverage on Five Stocks To Buy: Hindustan Zinc, Glenmark Pharmaceuticals, SRF And Two More - NDTV Profit

Five Stocks To Buy: Hindustan Zinc, Glenmark Pharmaceuticals, SRF And Two More  NDTV Profit

Five Stocks To Buy: Hindustan Zinc, Glenmark Pharmaceuticals, SRF And Two More - NDTV Profit

Click here to get full coverage on Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer - PR Newswire

Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer  PR Newswire

GLENMARK

Price Chart

Key Statistics

Technicals

About GLENMARK

Latest News

Glenmark bags multi-regional rights to Hansoh Pharma’s oncology drug for $1 B - BioSpectrum Asia

NJ-based Glenmark Pharmaceuticals recalls blood pressure medication - Bergen Record

Popular blood pressure medication recalled: Complete list of products - AL.com

Advanced Charts

Top Gainers

Top Losers